使用基于深度转移学习技术的DenseNet-201对阿尔茨海默病的分类
Zia-Ur-Rehman1, Mohd Khalid Awang1, Javed Rashid2,3,4
1Faculty of Informatics and Computing, Universiti Sultan Zainal Abidin (UniSZA), Terengganu, Malaysia.
PloS one
|September 6, 2024
概括
这项研究引入了使用DenseNet-201和MRI扫描来准确检测阿尔茨海默病的深度学习模型. 该模型在分类不同痴呆症阶段时达到98.24%的准确性,有助于早期诊断.
科学领域:
- 神经成像是一种神经成像.
- 人工智能的人工智能
- 医学诊断 医学诊断 医学诊断
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特点是记忆力丧失.
- 由于缺乏明确的治疗或治愈方法,早期发现AD至关重要.
- 磁共振成像 (MRI) 是AD诊断的关键神经成像方式.
研究的目的:
- 开发和评估一个深度学习模型来分类阿尔茨海默病的不同阶段.
- 通过使用DenseNet-201架构来利用转移学习来使用MRI扫描进行AD诊断.
- 通过先进的计算方法提高AD检测的准确性和可靠性.
主要方法:
- 利用基于DenseNet-201的转移学习方法进行AD分类.
- 采用了MRI扫描数据集,分为五类:非痴呆 (ND),中度痴呆 (MOD),轻度痴呆 (MD),非常轻度痴呆 (VMD) 和严重痴呆 (SD).
- 实施数据增强技术以提高数据集大小和模型性能.
主要成果:
- 提出的深度学习模型实现了98.24%的高分类精度.
- 该模型在AD诊断中与现有和最先进的方法相比,表现优越.
- 该研究证实了该模型的实用性和可靠性,用于识别阿尔茨海默氏病的各个阶段.
结论:
- 开发的DenseNet-201模型提供了一个高度准确和有效的工具,用于使用MRI诊断阿尔茨海默病.
- 这种深度学习方法对早期和可靠的AD阶段检测有很大的前景.
- 这些发现支持将先进的人工智能技术集成到临床神经成像中,用于神经退行性疾病管理.
相关概念视频
01:26Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
01:30Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
01:22Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170